Despite the improvement of antibiotics prophylaxis, surgical technique, and immunosuppressive regimen following kidney transplantation (KT), urinary tract infections (UTIs) remain the most common infectious complication that can substantially interfere with the patients' quality of life. Studies within the last decade have reported the incidence of UTIs ranging from 25% to 75%, which varies widely likely due to differences in definition, diagnostic criteria, study design, and length of observation]. It has been reported that female sex, older age of the recipient, acute rejection episodes, and cadaveric donor were associated with higher risks of UTI. In patients with such an immunologically impaired condition, components of the adaptive cellular immunity are significantly reduced; however, innate components and humoral factors with probable defense mechanism remain relatively stable.
We have recently proven that the Fc gamma receptor (FcγR) single-nucleotide polymorphisms (SNPs) in liver transplant recipients were greatly associated with the susceptibility to post-transplant bloodstream infection.
In differences were observed with respect to the incidence of CMV or fungal infections between those variants. Therefore, the FCGR3A F carrier may contribute to be the foremost risk factor for the occurrence of postoperative UTI within 1 month following KT.
In conclusion, the FCGR3A gene SNP in KT recipients was significantly associated with the susceptibility to post-transplant UTI. This fact suggests that the immunosuppression therapy and antimicrobial surveillance can be adjusted by identifying the FcγR SNPs, leading to personalized medicine.
